This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,406.70 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a prescription pharmaceutical product. The award has an ultimate completion date of May 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,291.53 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a medical product. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,801.63 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,051.68 and a completion date of June 13, 2025. The award is for the supply of the drug NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, SPE2DX15D3005|SPE2DX24F3QLW, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is for the delivery of the pharmaceutical product Naropin 0.5% 100 mg/20 ml vial, 20 ml, with a firm fixed price ceiling value of $1,435.80 and a performance period through March 29, 2024. This award is not set aside and is part of Amerisourcebergen Drug...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,398.46 order is for 4564184800 units of the pharmaceutical product Naropin 0.5%, 150 mg/30 mL vials. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $348.68 delivery order by the Defense Logistics Agency to supply 4561917760 NAROPIN 1% 200 MG/20 ML VIAL 20ML. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between August 23rd and August 24th, 2023. No additional details were provided regarding the original solicitation or any overarching contract vehicles. The Defense Logistics Agency supports...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,611.38, is for the delivery of Naropin 0.2% 400 mg/200 ml bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 24, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,805.82 firm fixed-price delivery order contract is for the provision of 4564431836 ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a medical product. The contract has an ultimate completion date of April 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $7,717.05 firm fixed-price delivery order is for the supply of 4564294577 - ROPIVACAINE 0.2% 200 MG/100 ML 100ML, a pharmaceutical product. The contract has an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...